Marc Rubin

Safety and Efficacy of Lamivudine-Zidovudine Combination Therapy in Antiretroviral-Naive Patients

Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility

Characterization of a canine homolog of hepatitis C virus

Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants

Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

Assay of Plasma Samples Representing Different HIV-1 Genetic Subtypes: An Evaluation of New Versions of the Amplicor HIV-1 Monitor Assay

Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA

Functional diversity of helper T lymphocytes

Discontinuation of Antimicrobial Therapy for Febrile, Neutropenic Children with Cancer: A Prospective Study

Lamivudine for chronic delta hepatitis

Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine

Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule.

Beta-Lactam Antibiotic Therapy in Febrile Granulocytopenic Patients

Durability of Serologic Response After Lamivudine Treatment of Chronic Hepatitis B

HIV viral load markers in clinical practice

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders

A view on drug resistance in cancer

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Cytokines in the treatment of fungal infections

Evaluation of Chronic Hepatitis B Virus (HBV) Infection in Coinfected Patients Receiving Lamivudine as a Component of Anti-Human Immunodeficiency Virus Regimens

Trends in immunotherapy of fungal infections

A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B

Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients

Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition

Agricultural sustainability and intensive production practices

Clinical practice patterns of managing low-risk adult febrile neutropenia during cancer chemotherapy in the USA

Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

Antimicrobial therapy of unexplained fever in neutropenic patients

Molecular diagnosis of viral hepatitis

Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation

A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies

Hepatitis B Virus Infection

Management of hepatitis B: 2000—Summary of a workshop

Imipenem - Cilastatin versus Sulbactam - Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients

Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

Diagnosis of Venous Access Port--Related Infections

Bacteremic Pneumonia in Neutropenic Patients With Cancer

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

Converting Cancer Therapies into Cures: Lessons from Infectious Diseases

Stopping Antibiotic Therapy in Neutropenic Patients

CpG motifs in bacterial DNA trigger direct B-cell activation

Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

Changing Epidemiology of Infections in Patients with Neutropenia and Cancer: Emphasis on Gram-Positive and Resistant Bacteria

Approach to the Patient with Prolonged Granulocytopenia

Mutations in Hepatitis B Dna Polymerase Associated With Resistance to Lamivudine Do Not Confer Resistance to Adefovir In Vitro

Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy

Human Mycoses: Drugs and Targets for Emerging Pathogens

A TH1→TH2 switch is a critical step in the etiology of HIV infection

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Effects of Macrophage Colony-Stimulating Factor on Antifungal Activity of Mononuclear Phagocytes against Aspergillus fumigatus

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1

Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient

Inducible  -Lactamases: Clinical and Epidemiologic Implications for Use of Newer Cephalosporins

Effect of virological response on post‐treatment durability of lamivudine‐induced HBeAg seroconversion

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene

HIV-1 antibody serum negativity with urine positivity

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

New Trends in Patient Management: Risk-Based Therapy for Febrile Patients with Neutropenia

Hematopoietic growth factors in cancer patients with invasive fungal infections

Home treatment of febrile neutropenia: An empirical oral antibiotic regimen

Early Discharge Of Pediatric Febrile Neutropenic Cancer Patients By Substitution Of Oral For Intravenous Antibiotics

Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia

1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever

Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia

EXPERIENCE WITH CEFEPIME VERSUS MEROPENEM AS EMPIRIC MONOTHERAPY FOR NEUTROPENIA AND FEVER IN PEDIATRIC PATIENTS WITH SOLID TUMORS

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy

Vancomycin, Ticarcillin, and Amikacin Compared with Ticarcillin-Clavulanate and Amikacin in the Empirical Treatment of Febrile, Neutropenic Children with Cancer

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy

Trends in the postmortem epidemiology of invasive fungal infections at a University Hospital

Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients

A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors

Association of Plasma Human Immunodeficiency Virus Type 1 RNA Level withRisk of Clinical Progression in Patients with Advanced Infection

Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials

Is Monotherapy for Febrile Neutropenia Still a Viable Alternative?

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B

Chronic hepatitis B

The L-Arginine-Nitric Oxide Pathway

Ymdd Motif in Hepatitis B Virus Dna Polymerase Influences on Replication and Lamivudine Resistance: A Study By In Vitro Full–Length Viral Dna Transfection

Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

Cefepime as Empirical Monotherapy in Febrile Patients with Hematological Malignancies and Neutropenia: A Randomized, Single-Center Phase II Trial

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

Early Discharge of Low‐Risk Febrile Neutropenic Children and Adolescents with Cancer

Increased risk of adefovir resistance in patients with lamivudine‐resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy†

Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer

Short Courses of Intravenous Empirical Antibiotic Treatment in Selected Febrile Neutropenic Children with Cancer

Combination Immunotherapy and Antifungal Chemotherapy

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B

The challenge of emerging and re-emerging infectious diseases

Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.

A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile Neutropenia

Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study

Antifungal Activity Of Elutriated Human Monocytes Against Aspergillus Fumigatus Hyphae: Enhancement By Granulocyte-Macrophage Colonystimulating Factor And Interferon-a

Vancomycin as Part of Initial Empirical Antibiotic Therapy for Febrile Neutropenia in Patients with Cancer: Pros and Cons

A Multicenter, Double‐Blind, Placebo‐Controlled Trial Comparing Piperacillin‐Tazobactam with and without Amikacin as Empiric Therapy for Febrile Neutropenia

Efficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Befficacy of Lamivudine in Patients With Hepatitis B E Antigen-Negative/Hepatitis B Virus Dna-Positive (Precore Mutant) Chronic Hepatitis Bb

Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer Patients

Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients

Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy

Vancomycin versus Placebo for Treating Persistent Fever in Patients with Neutropenic Cancer Receiving Piperacillin-Tazobactam Monotherapy

A Microchip CD4 Counting Method for HIV Monitoring in Resource-Poor Settings

A One-Year Trial of Lamivudine for Chronic Hepatitis B

Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States

The Role of Bronchoalveolar Lavage in the Microbiological Diagnosis of Pneumonia in Patients with Haematological Malignancies

Recent Experience With Pseudomonas aeruginosa Bacteremia in Patients With Cancer

Subtype-specific problems with quantification of plasma HIV-1 RNA

Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients

Pulmonary host defences against Aspergillus fumigatus

Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients

Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial

Mutation in Hbv Rna–Dependent Dna Polymerase Confers Resistance to Lamivudine In Vivo

Comparison of Amphotericin B Lipid Complex (ABLC) vs. AmBisome in the Treatment of Suspected or Documented Fungal Infections in Patients with Leukemia

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).

Towards improvements in molecular tools for diagnosis and management of HIV infections

Defining the Anthropocene

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

Current Status of Granulocyte (Neutrophil) Transfusion Therapy for Infectious Diseases

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials

The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia

A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients

Treatment of febrile neutropenic patients with cancer who require hospitalization

Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine

Antimicrobial peptides of multicellular organisms

Vancomycin does not benefit persistently febrile neutropenic people with cancer

Microfluidic diagnostic technologies for global public health

Amphotericin B Lipid Complex (Abelcet®) in the treatment of invasive mycoses: the North American experience

Granulocyte Colony‐Stimulating Factor Administered In Vivo Augments Neutrophil‐Mediated Activity against Opportunistic Fungal Pathogens

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia

Predicting the risk of bacteremia in childen with fever and neutropenia.

The treatment of febrile neutropenia: from the Dark Ages to the present

Evaluation of antiretrovirals in animal models of HIV infection

Prevention of Invasive Fungal Infections in Patients with Neoplastic Diseases

A prospective study comparing vancomycin and teicoplanin as second‐line empiric therapy for infection in neutropenic patients

A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B

β-Lactam regimens for the febrile neutropenic patient

Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion

An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients

Randomized, Double-Blind, Multicenter Trial Comparing Clinafloxacin with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients

Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

Assessment of Measuring Circulating Levels of Interleukin‐6, Interleukin‐8, C‐Reactive Protein, Soluble Fcy Receptor Type III, and Mannose‐Binding Protein in Febrile Children with Cancer and Neutropenia

Fever of Unknown Origin in Febrile Leukopenia

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection

Long-term therapy of chronic hepatitis B with lamivudine

Adherence to Medication

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

Changes in Plasma HIV RNA Levels and CD4+ Lymphocyte Counts Predict Both Response to Antiretroviral Therapy and Therapeutic Failure

Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial

Fungal infections: a growing threat.

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future [published erratum appears in Blood 1991 Dec 15;78(12):3330]

How should imipenem-cilastatin be Used in the treatment of fever and infection in neutropenic cancer patients?

Molecular Targets for AIDS Therapy

Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation

The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis

Resistance of enterococci to glycopeptides

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program

Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon

Prevention and Treatment of Cancer-Related Infections

Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients

Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo

Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.

Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae.

Transferable vancomycin and teicoplanin resistance in Enterococcus faecium

Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor

A Bispecific Antibody Composed of a Nonneutralizing Antibody to the gp41 Immunodominant Region and an Anti-CD89 Antibody Directs Broad Human Immunodeficiency Virus Destruction by Neutrophils

Biodiversity Conservation and the Eradication of Poverty

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy

Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance

Granulocyte-macrophage colony-stimulating factor and interferon-γ prevent dexamethasone-induced immunosuppression of antifungal monocyte activity againstAspergillus fumigatushyphae

Ceftazidime Plus Amikacin Versus Ceftazidime Plus Vancomycin as Empiric Therapy in Febrile Neutropenic Children with Cancer

Empirical Antimicrobial Therapy for Febrile Granulocytopenic Cancer Patients: Lessons from Four EORTC Trials

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia

Positive Effects of Combined Antiretroviral Therapy on CD4 ⁺ T Cell Homeostasis and Function in Advanced HIV Disease

The Critical Role of p38 MAP Kinase in T Cell HIV-1 Replication

2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues

Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

Is there a rationale for the use of antimicrobial prophylaxis in neutropenic patients?

Production of cytokines by alveolar and peritoneal macrophages stimulated byAspergillus fumigatusconidia or hyphae

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

Gene correction in hematopoietic progenitor cells by homologous recombination

In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus

Time to Clinical Response: An Outcome of Antibiotic Therapy of Febrile Neutropenia With Implications for Quality and Cost of Care

Viral dynamics in hepatitis B virus infection.

Outcomes and Cost of Outpatient or Inpatient Management of 712 Patients With Febrile Neutropenia

Empiric Monotherapy for Febrile Neutropenia - a Randomized Study Comparing Meropenem with Ceftazidime

The Crisis in Antibiotic Resistance

Aspergillus fumigatusand Aspergillosis

Climate Warming and Disease Risks for Terrestrial and Marine Biota

Growth Factors and Cancer

Experimental models in antifungal chemotherapy

Viral Counts Count in HIV Infection

A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer)

Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors

Defaunation in the Anthropocene

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with β-branched amino acids

Inhibitors of human immunodeficiency virus integrase.

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity

Epidemiology of nosocomial fungal infections

Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy

Serum HIV-1 RNA Levels and Time to Development of AIDS in the Multicenter Hemophilia Cohort Study

Phylogenetic Perspectives in Innate Immunity

Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination

Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models

Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon

Efficacy of LY303366 against Amphotericin B-Susceptible and -Resistant Aspergillus fumigatus in a Murine Model of Invasive Aspergillosis

The Medical Course of Cancer Patients With Fever and Neutropenia

Functional requirements of AID’s higher order structures and their interaction with RNA-binding proteins

Humans as the World's Greatest Evolutionary Force

Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients

Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction

Empiric Therapy with Amphotericin B in Febrile Granulocytopenic Patients

Effects of Preventive, Early, and Late Antifungal Chemotherapy with Fluconazole in Different Granulocytopenic Models of Experimental Disseminated Candidiasis

A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

Controversies in the Management of Febrile Neutropenic Cancer Patients

Helper T-cell responses in children infected with human immunodeficiency virus type 1

Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor

Granulocyte Colony-Stimulating Factor Enhances the Phagocytic and Bactericidal Activity of Normal and Defective Human Neutrophils

A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients.

Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV Infection

Stimulatory effect of counterflow centrifugal elutriation in large‐scale separation of peripheral blood monocytes can be reversed by storing the cells at 37°c

Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS

The child with cancer and infection. II. Nonbacterial infections

Association of Gag Multimers with Filamentous Actin During Equine Infectious Anemia Virus Assembly

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.

Experimental Basis for Use of Fluconazole for Preventive or Early Treatment of Disseminated Candidiasis in Granulocytopenic Hosts

The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies

Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic Millimeter

A Phase I/II Study of 2'-Deoxy-3'-Thiacytidine (Lamivudine) in Patients with Advanced Human Immunodeficiency Virus Infection

Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients

Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy

Effects of antifungal agents on the function of human neutrophils in vitro

Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.

A Randomized Trial Comparing Ceftazidime Alone With Combination Antibiotic Therapy in Cancer Patients With Fever and Neutropenia

Gram-Positive Infections and the Use of Vancomycin in 550 Episodes of Fever and Neutropenia

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia

Leptotrichia buccalis Bacteremia in Patients with Cancer: Report of Four Cases and Review

Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy

Lamivudine treatment for one year in previously untreated U.S. hepatitis B patients: histologic improvement and hepatitis be-antigen (HBeAg) seroconversion

Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection